Drug
11c Abbv 112i
11c Abbv 112i: highest development phase Phase 1, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| [11C]ABBV-112i NCT07933497 | Phase 1 |
Latest
No recent events.
Follow 11c Abbv 112i on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.